CareDx Reports Third-Quarter 2026 Financial Results
CareDx reported results for the quarter ended September 30, 2026. The supplied excerpt does not include financial figures.
CareDx, Inc. (NASDAQ:CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today reported financial results for the third quarter ended September 30, 2026.Third Quarter 2026 Financial HighlightsRecent Business Highlights“We delivered another s…